Topical NSAIDs for chronic musculoskeletal pain in adults

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Derry, Sheena ^a   Conaghan, Philip ^b   Da Silva, José António P ^c   Wiffen, Philip J ^a   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; ETORICOXIB; FELBINAC; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIKETOPROFEN; PIROXICAM; PLACEBO;

ADULT; BIBLIOGRAPHIC DATABASE; CHRONIC MUSCULOSKELETAL PAIN; CHRONIC PAIN; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA COLLECTION METHOD; DATA EXTRACTION; DATA SYNTHESIS; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBASE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HUMAN; KNEE OSTEOARTHRITIS; MEDICAL INFORMATION; MEDLINE; META ANALYSIS; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; NUMBERS NEEDED TO TREAT; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN INTENSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REST; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC PAIN; DICLOFENAC; HUMANS; KETOPROFEN; MUSCULOSKELETAL PAIN; NUMBERS NEEDED TO TREAT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84964354542     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007400.pub3     Document Type: Review

References (109)

1. A double-blind, multi-centred, randomized, placebo-controlled, four-way parallel, clinical trial designed to confirm the safety and efficacy of PENNSAID™ in the treatment of osteoarthritic knee. Data supplied by Nuvo.
2. A double-blinded, placebo-controlled, four-way parallel, clinical trial to evaluate the safety and efficacy of PENNSAID™ treatment of the osteoarthritic hand. Data supplied by Nuvo.
3. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. Journal of Rheumatology 2009;36(9):1991-9. [DOI: 10.3899/jrheum.081316]
4. Novartis (Sponsor). Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis. www.clinicaltrials.gov/ct2/show/NCT00171665 (accessed 9 February 2016) 2015. [CTG: NCT00171665]
5. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskeletal Disorders 2005;6:44. [DOI: 10.1186/1471-2474-6-44]
6. Balthazar-Letawe D. Voltaren Emulgel in clinical rheumatology. Comparative trial with Indocid gel [Voltaren Emulgel en pratique rhumatologique. Essai comparatif avec Indocid gel]. Acta Belgica Medica Physica 1987;10:109-10.
7. Efficacy and safety of diclofenac sodium gel (DSG) in knee osteoarthritis [NCT00426621]. www.ClinicalTrials.gov [accessed 14 February 2012] 2007.
8. Efficacy and safety of diclofenac sodium gel in knee osteoarthritis [NCT00171678]. www.ClinicalTrials.gov [accessed 14 February 2012] 2007.
9. Baraf HS, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging 2011;28(1):27-40.
10. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Seminars in Arthritis and Rheumatism 2009;39(3):203-12. [DOI: 10.1016/j.semarthrit.2009.09.002]
11. Bolten W. Felbinac gel for treatment of localized extra-articular rheumatic diseases - a multicenter, placebo [Felbinac-Gel zur Behandlung lokalisierter extraartikulärer rheumatischer Beschwerden - eine multizentrische, placebokontrollierte, randomisierte Studie]. Zeitschrift für Rheumatologie 1991;50:109-13.
12. Bookman AM, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004;171(4):333-8. [DOI: 10.1503/cmaj.1031793]
13. Brühlmann P, Michel BA. Topical diclofenac patch in patients. Clinical and Experimental Rheumatology 2003;21:193-8.
14. Burgos A, Busquier MP, Reino JG, Ferreiro JL, Navarro F, Valverde J, et al. Double-blind, double-dummy comparative study of local action transcutaneous flurbiprofen (flurbiprofenLAT) versus piketoprofen cream in the treatment of extraarticular rheumatism. Clinical Drug Investigation 2001;21:95-102.
15. Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford) 2013;52(7):1303-12. [DOI: 10.1093/rheumatology/ket133]
16. Dickson DJ. A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Current Therapeutic Research 1991;49:199-07.
17. Dreiser RL, Tisne-Camus M. DHEP plasters as a topical treatment of knee osteoarthritis - a double-blind placebo-controlled study. Drugs Under Experimental and Clinical Research 1993;19:117-23.
18. Ergün H, Külcü D, Kutlay S, Bodur H, Tulunay FC. Efficacy and safety of topical nimesulide in the treatment of knee osteoarthritis. Journal of Clinical Rheumatology 2007;13(5):251-55. [DOI: 10.1097/RHU.0b013e318156b85f]
19. Galeazzi M, Marcolongo R. A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs Under Experimental and Clinical Research 1993;19:107-15.
20. Grace D, Rogers J, Skeith K, Anderson K. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. Journal of Rheumatology 1999;26:2659-63.
21. Gui L, Pellacci F, Ghirardini G. Use of ibuprofen cream in ambulatory orthopedic patients. Double blind comparison with placebo [Impiego dell'ibuprofen crema inpazienti ambulatoriali di interesse ortopedico. Confronto indoppia cecità con placebo]. Clinical Therapeutics 1982;101:363-9.
22. Hohmeister R. Treatment of rheumatic diseases of soft tissues with Mobilisin Gel. Results of a double blind study [Die Behandlung von weichteilrheumatischenErkrankungen mit Mobilisin Gel. Resultate einer Doppelblind-Studie]. Fortschritte der Medizin 1983;101:1586-8.
23. Kneer W, Rother M, Mazgareanu S, Seidel EJ, European IDEA-033 study group. A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome® gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. Journal of Pain Research 2013;6:743-53. [DOI: 10.2147/JPR.S51054]
24. Link R, Balint G, Pavlik G, Otto J, Krause W. Topical treatment of soft tissue rheumatism and athletic injuries. Effectiveness and tolerance of a new ketoprofengel [Topische Behandlungvon Weichteil-rheumatismus und Sportverletzungen. Wirksamkeitund Verträglichkeit eines neuen Ketoprofengels]. Fortschritte der Medizin 1996;114:311-4.
25. McCleane G. The addition of piroxicam to topically applied glyceryl trinitrate enhances its analgesic effect in musculoskeletal pain: a randomised, double-blind, placebo-controlled study. Pain Clinic 2000;12:113-6.
26. Merck Sharp, Dohme Corp (Sponsor). A study to assess the single dose pharmacokinetics of two and proof of efficacy of one new etoricoxib gel formulation in osteoarthritis patients. www.clinicaltrials.gov/ct2/show/NCT01980940 (accessed 19 November 2015) 2015. [CTG: NCT01980940]
27. Niethard FU, Gold MS, Solomon GS, Liu JH, Unkauf M, Albrecht HH, et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. Journal of Rheumatology 2005;32(12):2384-92.
28. Ottillinger B, Gomor B, Michel BA, Pavelka K, Beck W, Elsasser U. Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2001;9:273-80. [DOI: 10.1053/joca.2000.0385]
29. Poul J, West J, Buchanan N, Grahame R. Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. British Journal of Rheumatology 1993;32:1000-03. [DOI: 10.1093/rheumatology/32.11.1000]
30. Rose W, Manz G, Lemmel EM. Topical application of piroxicam-gel in the treatment of activated gonarthrosis [Behandlung der aktivierten gonarthrose mit topisch appliziertem piroxicam-gel]. Munchener Medizinische Wochenschrift 1991;133:562-6.
31. Roth SH. A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. International Journal of Tissue Reactions 1995;4:129-32.
32. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee. Archives of Internal Medicine 2004;164:2017-23.
33. Rother M, Lavins BJ, Kneer W, Lehnhardt K, Egbert J, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Annals of the Rheumatic Diseases 2007;66:1178-83. [DOI: 10.1136/ard.2006.065128]
34. Rother M, Conaghan PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. Journal of Rheumatology 2013;40(10):1742-8. [DOI: 10.3899/jrheum.130192]
35. Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskahl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scandinavian Journal of Rheumatology 1997;26:287-92.
36. Simon LS, Grierson LM, Naseer Z, Bookman AA, Shainhouse JZ. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009;143(3):238-45. [DOI: 10.1016/j.pain.2009.03.008]
37. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. Journal of Rheumatology 2004;31(10):2002-12.
38. van Haselen RA, Fisher PA. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee. Rheumatology 2000;39:714-9.
39. Varadi G, Zhu Z, Blattler T, Hosle M, Loher A, Pokorny R, et al. Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis. Pain Physician 2013;16(6):E749-62. [PUBMED: 24284856]
40. Widrig R, Suter A, Saller R, Melzer J. Choosing between NSAID and arnica for topical treatment. Rheumatology International 2007;27:585-91. [DOI: 10.1007/s00296-007-0304-y]
41. Zacher J, Burger KJ, Farber L, Grave M, Abberger H, Bertsch K. Topical diclofenac versus oral ibuprofen: a double blind, randomized clinical trial to demonstrate efficacy and tolerability in patients with activated osteoarthritis of the finger joints (Heberden and/or Bouchard arthritis). Aktuelle Rheumatologie 2001;26:7-14.
42. Allegrini A, Nuzzo L, Pavone D, Tavella-Scaringi A, Giangreco D, Bucci M, et al. Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study. Arzneimittel-Forschung 2009;59(8):403-9.
43. Di Rienzo Businco L, Di Rienzo Businco A, D'Emilia M, Lauriello M, Coen Tirelli G. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms [Confronto diclofenac topico versus sistemico nel trattamento dei sintomi da disfunzione dell'articolazione temporo-mandibolare]. Acta Otorhinolaryngologica Italica 2004;24(5):279-83.
44. Doi T, Akai M, Fujino K, Hoshino Y, Iwaya T, Sunami Y. Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomised controlled trial. Modern Rheumatology 2010;20:24-33.
45. Fotiades P, Bach GL. The effect of a flufenamic acid containing ointment in various rheumatic diseases [Wirkung einer flufenaminsaurehaltigen Salbe bei verschiedenen rheumatischen Erkrankungen]. Fortschritte der Medizin 1976;94:1036-8.
46. Galer BS. A comparative subjective assessment study of Pennsaid and Voltaren gel, two topical formulations of diclofenac sodium. Pain Practice 2011;11(3):252-60.
47. Geller O. Comparison of a salicylate heparin gel with a monosubstance preparation. Results of a double blind cross over study [Vergleich eines Salizylat/Heparin-Gels mit einemMono-substanzpräparat. Ergebnisse einer Doppelblindcross-over-Studie.]. Munchener Medizinische Wochenschrift 1980;122:1231-2.
48. Ginsberg F, Famaey JP. Double-blind, randomized cross-over study of the percutaneous efficacy and tolerability of a topical indomethacin spray versus placebo in the treatment of tendinitis. Journal of Internal Medicine 1991;19:131-6.
49. Mattara L, Trotta F, Biasi D, Cervetti R. Evaluation of the efficacy and tolerability of a new locally acting preparation of flurbiprofen in scapulohumeral periarthritis. European Journal of Rheumatology and Inflammation 1994;4:15-20.
50. Peniston JH, Gold MS, Alwine LK. An open-label, long-term safety and tolerability trial of diclofenac sodium 1% gel in patients with knee osteoarthritis. The Physician and Sportsmedicine 2011;39(3):31-8. [DOI: 10.3810/psm.2011.09.1918]
51. Rovensky J, Micekova D, Gubzova Z, Fimmers R, Lenhard G, Vogtle-Junkert U, et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Under Experimental and Clinical Research 2001;27:209-21.
52. Tiso RL, Tong-Ngork S, Fredlund KL. Oral versus topical ibuprofen for chronic knee pain: a prospective randomised pilot study. Pain Physician 2010;13:457-67.
53. Trnavský K, Fischer M, Vögtle-Junkert U, Schreyger F. Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. Journal of Rheumatology 2004;31(3):565-72.
54. Underwood M, Ashby D, Carnes D, Castelnuovo E, Cross P, Harding G, et al. Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technology Assessment 2008;12:22.
55. Verkleij SP, Luijsterburg PA, Willemsen SP, Koes BW, Bohnen AM, Bierma-Zeinstra SM. Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: a randomised controlled trial in primary care. British Journal of General Practice 2015;65(637):e530-7. [DOI: 10.3399/bjgp15X686101]
56. Vitali G. Controlled clinical experiment with the topical use of 2-(3-benzoyl-phenyl) propionic acid at 3 different concentrations [Sperimentazione clinica controllata sull'impiego topicodell'acido 2-(3-benzoil-fenil) proprionico a tre diverse concentrazioni]. Clinical Therapeutics 1980;94:257-73.
57. Bohlooli S, Jastan M, Nakhostin-Roohi B, Mohammadi S, Baghaei Z. A pilot double-blinded, randomized, clinical trial of topical virgin olive oil versus piroxicam gel in osteoarthritis of the knee. Journal of Clinical Rheumatology 2012;18(2):99-101. [DOI: 10.1097/RHU.0b013e31824a47b5]
58. Niempoog S, Siriarchavatana P, Kajsongkram T. The efficacy of Plygersic gel for use in the treatment of osteoarthritis of the knee. Journal of the Medical Association of Thailand 2012;95 Suppl 10:S113-9. [PUBMED: 23451449]
59. Phillips K (Principal investigator). Central pain mechanisms in osteoarthritis: a randomized, double-blind, crossover study to evaluate the effectiveness of topical diclofenac versus duloxetine for chronic osteoarthritis pain. www.clinicaltrials.gov/ct2/show/record/NCT01377038 (accessed 19 November 2015) 2015. [CTG: NCT01377038]
60. FPR Specialty Pharmacy. Treatment of knee pain with topical diclofenac cream 8% or diclofenac gel 1%. www.clinicaltrials.gov/ct2/show/NCT02068859 (accessed 19 November 2015) 2014. [CTG: NCT02068859]
61. Prayag Shah, MD (Study director). A multi-center, double-blind, vehicle-controlled, parallel-group study comparing a generic diclofenac sodium topical gel, 1% to Voltaren® gel (diclofenac sodium topical gel) 1% in the treatment of subjects with osteoarthritis of the knee. www.clinicaltrials.gov/ct2/show/NCT02121002 (accessed 19 November 2015) 2015. [CTG: NCT02121002]
62. Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs 2011;71(10):1259-79. [DOI: 10.2165/11592550-000000000-00000]
63. Anon . Topical analgesics: a review of reviews and a bit of perspective. www.medicine.ox.ac.uk/bandolier/Extraforbando/Topextra3.pdf (accessed 18 November 2015) 2005.
64. Barthel HR, Axford-Gatley RA. Topical nonsteroidal anti-inflammatory drugs for osteoarthritis. Postgraduate Medicine 2010;122(6):98-106. [DOI: 10.3810/pgm.2010.11.2227]
65. Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: meta-analysis of randomized placebo controlled clinical trials. Journal of Rheumatology 2006;33(9):1841-4.
66. Bjordal JM, Klovning A, Ljunggren AE, Slørdal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. European Journal of Pain 2007;11(2):125-38. [DOI: 10.1016/j.ejpain.2006.02.013]
67. Conaghan PG, Bijlsma JW, Kneer W, Wise E, Kvien TK, Rother M. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety. Current Medical Research and Opinion 2014;30(4):599-611. [DOI: 10.1185/03007995.2013.860018]
68. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
69. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:f2304. [DOI: 10.1136/bmj.f2304]
70. Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010111]
71. Derry S, Sven-Rice A, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3]
72. Derry S, Matthews PR, Wiffen PJ, Moore RA. Salicylate-containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD007403.pub3]
73. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD007402.pub3]
74. Dougados M, Leclaire P, van der Heijde D, Bloch DA, Bellamy N, Altman RD. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage 2000;8(6):395-403. [DOI: 10.1053/joca.2000.0361]
75. Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995;311(6996):22-6.
76. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine 2001;345(6):433-42. [DOI: 10.1056/NEJM200108093450607]
77. Gaskell H, Derry S, Moore RA. Treating chronic non-cancer pain in older people--more questions than answers?. Maturitas 2014;79(1):34-40. [DOI: 10.1016/j.maturitas.2014.06.013]
78. McMaster University (developed by Evidence Prime, Inc.) . GRADEpro Guideline Development Tool [Software]. Available from www.gradepro.org (accessed 11 February 2016), 2015.
79. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Medicine 2010;11(4):535-49. [DOI: 10.1111/j.1526-4637.2010.00809.x]
80. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
81. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2-3):239-46. [DOI: 10.1016/0304-3959(96)03033-3]
82. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12. [DOI: 10.1016/0197-2456(95)00134-4]
83. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
84. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329(7461):324. [DOI: 10.1136/bmj.38159.639028.7C]
85. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BioMed Central Family Practice 2004;5:10. [DOI: 10.1186/1471-2296-5-10]
86. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BioMed Central Musculoskeletal Disorders 2004;5:28. [DOI: 10.1186/1471-2474-5-28]
87. McPherson ML, Cimino NM. Topical NSAID formulations. Pain Medicine 2013;14 Suppl 1:S35-9. [DOI: 10.1111/pme.12288]
88. Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ (Clinical Research Ed) 1998;316(7128):333-8.
89. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
90. Moore RA, Derry S, McQuay HJ. Topical agents in the treatment of rheumatic pain. Rheumatic Disease Clinics of North America 2008;34(2):415-32. [DOI: 10.1016/j.rdc.2008.03.006]
91. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
92. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. [DOI: 10.1016/j.pain.2010.05.011]
93. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. [DOI: 10.1136/ard.2009.107805]
94. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153(2):265-8. [DOI: 10.1016/j.pain.2011.10.004]
95. Moore RA, Straube S, Aldington D. Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome. Anaesthesia 2013;68(4):400-12. [DOI: 10.1111/anae.12148]
96. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with Confidence - Confidence Intervals and Statistical Guidelines. London: British Medical Journal, 1995:50-63.
97. National Collaborating Centre for Chronic Conditions. Osteoarthritis: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians, 2008. [ISBN: 978-1-86016-329-6]
98. Osteoarthritis. Care and management in adults. NICE clinical guideline 177. nice.org.uk/guidance/cg177/evidence 2014. [ISBN: 978-1-4731-0426-6]
99. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515. [DOI: 10.1136/bmj.c3515]
100. PaPaS author and referee guidance. http://papas.cochrane.org/papas-documents (accessed 9 March 2015).
101. Prescribing and Medicines Team, Health and Social Care Information Centre. Prescription Cost Analysis, England 2014. www.hscic.gov.uk/catalogue/PUB17274/pres-cost-anal-eng-2014-rep.pdf (accessed 11 February 2016). The NHS Information Centre, 2015:309-312. [ISBN: 978-1-78386-365-5]
102. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
103. Roth SH, Fuller P. Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. Journal of Pain Research 2011;4:159-67. [DOI: 10.2147/JPR.S20965]
104. Shainhouse JZ, Grierson LM, Naseer Z. A long-term, open-label study to confirm the safety of topical diclofenac solution containing dimethyl sulfoxide in the treatment of the osteoarthritic knee. American Journal of Therapeutics 2010;17(6):566-76. [DOI: 10.1097/MJT.0b013e3181d169b5]
105. Taylor RS, Fotopoulos G, Maibach H. Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Current Medical Research and Opinion 2011;27(3):605-22. [DOI: 10.1185/03007995.2010.550606]
106. Towheed TE. Pennsaid therapy for osteoarthritis of the knee: a systematic review and meta-analysis of randomized controlled trials. Journal of Rheumatology 2006;33(3):567-73. [DOI: 10.2147/JPR.S20965]
107. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997;315(7109):635-40.
108. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163-96. [DOI: 10.1016/S0140-6736(12)61729-2]
109. Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD007400.pub2]